Clinical Trial Update: Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing toripalimab with chemoradiotherapy for unresectable esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Mian XI | Conditions: Unresectable Esophageal Cancer | Phase 2 | Status: COMPLETED